COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES OF ENZALUTAMIDE FOR THE TREATMENT OF NON- METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN MEXICO
COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES OF ENZALUTAMIDE FOR THE TREATMENT OF NON- METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN MEXICO
dc.contributor.author | Ruiz, B | |
dc.contributor.author | Polanco, A | |
dc.contributor.author | Saturnino LMT | |
dc.contributor.author | Flores Aldana BA | |
dc.contributor.author | Gutierrez M | |
dc.date.accessioned | 2024-10-25T19:10:22Z | |
dc.date.available | 2024-10-25T19:10:22Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Ruiz B, Polanco A, Saturnino LTM, Flores Aldana BA, Gutierrez M. COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES OF ENZALUTAMIDE FOR THE TREATMENT OF NON- METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN MEXICO. VALUE IN HEALTH. 2022. doi: 10.1016/j.jval.2022.09.675 | |
dc.identifier.other | DOI: 10.1016/j.jval.2022.09.675 | |
dc.identifier.uri | https://dspace.inc.saude.gov.br/handle/123456789/539 | |
dc.language.iso | en | |
dc.publisher | VALUE IN HEALTH | |
dc.title | COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES OF ENZALUTAMIDE FOR THE TREATMENT OF NON- METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN MEXICO | |
dc.type | Article |